SUMMARY OF WARRANT ACTIVITY (Details) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Allocation Of Fair Value In Private Placement | ||
| Number of Warrants Outstanding, beginning of year | 16,675,364 | 1,292,030 |
| Weighted Average Exercise Price, Outstanding, beginning of year | $ 0.13 | |
| Weighted average remaining expected term, beginning of year | $ 4.6 | |
| Number of Warrants, Granted | 4,366,667 | |
| Weighted Average Exercise Price, Granted | $ 0.12 | |
| Weighted average remaining expected term, beginning of year | $ 5.0 | |
| Number of Warrants, Exercised | ||
| Weighted Average Exercise Price, Exercised | ||
| Number of Warrants, Forfeited/Cancelled | ||
| Weighted Average Exercise Price, Forfeited/Cancelled | ||
| Number of Warrants Outstanding, end of year | 21,042,031 | 1,292,030 |
| Weighted Average Exercise Price, Outstanding, end of year | $ 0.12 | |
| Weighted average remaining expected term, beginning of year | $ 4.6 | |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option exercised in period exercise price. No definition available.
|
| X | ||||||||||
- Definition ShareBased Compensation Arrangement by ShareBased Payment Award Non Option Forfeited Or Expired in Period Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option grand in period exercise price. No definition available.
|
| X | ||||||||||
- Definition ShareBased Compensation Arrangement By ShareBased Payment Award NonOption Outstanding Exercise Price Rage Number of Share. No definition available.
|
| X | ||||||||||
- Definition Exercise price. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|